Evaluation of Trastuzumab In Patients With HER2 Positive Persistent Or Recurrent Vulvar Paget's Disease
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Trastuzumab
Related studies linked through entity extraction aliases.
Combination of Weekly Paclitaxel With Neratinib and Trastuzumab in Women With Metastatic HER2-positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Phase II of AUY922 in Second-line Gastric Cancer in Combination With Trastuzumab in HER2 Positive Patients
- Status
- TERMINATED
- Phase
- PHASE2
Trial of Eribulin in Patients Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Study of Neoadjuvant Carboplatin, Eribulin and Trastuzumab for Operable HER2 Positive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio Immunotherapy
- Status
- COMPLETED
- Phase
- PHASE1
Intrathecal Trastuzumab Administration in Metastatic Breast Cancer Patients Developing Carcinomatous Meningitis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Dose Escalation Study of MLN0128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Neoadjuvant 5-fluorouracil, Epirubicin and Cyclophosphamide (FEC) Followed by Weekly Paclitaxel and Trastuzumab in Her2 Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Dasatinib In Combination With Trastuzumab And Paclitaxel In First Line Treatment Of Her2-Positive MBC Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study Of Everolimus, Trastuzumab And Vinorelbine In HER2-Positive Breast Cancer Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Herceptin (Trastuzumab) in Combination With a Taxane in Participants With HER2-Positive Breast Cancer Who Relapsed After (Neo)Adjuvant Herceptin Treatment
- Status
- COMPLETED
- Phase
- PHASE4
Study of BKM120 or BYL719 and Capecitabine in Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Taxotere®, Eloxatin® and Xeloda® (TEX) in Combination With Herceptin® as Treatment for HER2 Positive Non-resectable Cancer
- Status
- COMPLETED
- Phase
- NA
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Combination of AUY922 With Trastuzumab in HER2+ Advanced Breast Cancer Patients Previously Treated With Trastuzumab
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2